AAPL   389.21 (+1.44%)
FB   246.50 (+0.58%)
NVDA   424.57 (+1.29%)
MU   51.53 (+1.64%)
AAPL   389.21 (+1.44%)
FB   246.50 (+0.58%)
NVDA   424.57 (+1.29%)
MU   51.53 (+1.64%)
AAPL   389.21 (+1.44%)
FB   246.50 (+0.58%)
NVDA   424.57 (+1.29%)
MU   51.53 (+1.64%)
AAPL   389.21 (+1.44%)
FB   246.50 (+0.58%)
NVDA   424.57 (+1.29%)
MU   51.53 (+1.64%)
Log in

OTCMKTS:NRIFFNuvo Pharmaceuticals Stock Price, Forecast & News

$0.52
0.00 (0.00 %)
(As of 07/13/2020 08:55 AM ET)
Add
Compare
Today's Range
$0.52
Now: $0.52
$0.52
50-Day Range
$0.51
MA: $0.56
$0.60
52-Week Range
$0.24
Now: $0.52
$0.87
VolumeN/A
Average Volume3,449 shs
Market Capitalization$5.93 million
P/E Ratio13.00
Dividend YieldN/A
Beta1.51
Nuvo Pharmaceuticals Inc., a commercial healthcare company, produces and sells pharmaceutical products in the United States, Canada, and Europe. It offers Pennsaid, a topical pain product that is used to treat the signs and symptoms of osteoarthritis of the knee; Pennsaid 2%, a follow-on product to Pennsaid for the treatment of the pain of osteoarthritis of the knee; Heated Lidocaine/Tetracaine (HLT) Patch, a topical patch that provides local analgesia prior to painful needle procedures, such as dialysis, blood draws, and pediatric needles; and Resultz, an over-the-counter product intended to kill head lice and remove their eggs from hair. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.86 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:NRIFF
CUSIPN/A
CIKN/A
Phone905-673-6980

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$52.41 million
Cash Flow$0.85 per share
Book Value$1.59 per share

Profitability

Net Income$2.53 million

Miscellaneous

Employees97
Market Cap$5.93 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive NRIFF News and Ratings via Email

Sign-up to receive the latest news and ratings for NRIFF and its competitors with MarketBeat's FREE daily newsletter.

Nuvo Pharmaceuticals (OTCMKTS:NRIFF) Frequently Asked Questions

How has Nuvo Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Nuvo Pharmaceuticals' stock was trading at $0.6007 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NRIFF shares have decreased by 13.4% and is now trading at $0.52. View which stocks have been most impacted by Coronavirus.

When is Nuvo Pharmaceuticals' next earnings date?

Nuvo Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Nuvo Pharmaceuticals.

How were Nuvo Pharmaceuticals' earnings last quarter?

Nuvo Pharmaceuticals Inc (OTCMKTS:NRIFF) issued its quarterly earnings results on Monday, May, 11th. The company reported $0.12 earnings per share (EPS) for the quarter. The business had revenue of $18.16 million for the quarter. Nuvo Pharmaceuticals had a net margin of 17.41% and a return on equity of 4.76%. View Nuvo Pharmaceuticals' earnings history.

Has Nuvo Pharmaceuticals been receiving favorable news coverage?

Press coverage about NRIFF stock has trended very negative recently, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nuvo Pharmaceuticals earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Nuvo Pharmaceuticals.

Who are some of Nuvo Pharmaceuticals' key competitors?

Who are Nuvo Pharmaceuticals' key executives?

Nuvo Pharmaceuticals' management team includes the following people:
  • Mr. Robert Paul Harris, Exec. Chairman (Age 64)
  • Mr. Jesse F. Ledger, Pres & CEO
  • Ms. Mary-Jane E. Burkett CPA-CA, HBA, VP & CFO
  • Ms. Katina K. Loucaides M.Sc., LL.B, VP, Corp. Sec. & Gen. Counsel
  • Mr. Calogero Lunetta MSc, VP of Manufacturing

What is Nuvo Pharmaceuticals' stock symbol?

Nuvo Pharmaceuticals trades on the OTCMKTS under the ticker symbol "NRIFF."

How do I buy shares of Nuvo Pharmaceuticals?

Shares of NRIFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nuvo Pharmaceuticals' stock price today?

One share of NRIFF stock can currently be purchased for approximately $0.52.

How big of a company is Nuvo Pharmaceuticals?

Nuvo Pharmaceuticals has a market capitalization of $5.93 million and generates $52.41 million in revenue each year. Nuvo Pharmaceuticals employs 97 workers across the globe.

What is Nuvo Pharmaceuticals' official website?

The official website for Nuvo Pharmaceuticals is www.nuvopharmaceuticals.com.

How can I contact Nuvo Pharmaceuticals?

Nuvo Pharmaceuticals' mailing address is 6733 MISSISSAUGA ROAD SUITE 610, MISSISSAUGA A6, L5N 6J5. The company can be reached via phone at 905-673-6980 or via email at [email protected]

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.